Risk factors, survival, and impact of prophylaxis length in cytomegalovirus-seropositive lung transplant recipients: A prospective, observational, multicenter study.
Monforte V, Sintes H, López-Gallo C,  et al
Transpl Infect Dis. 2017 Mar 10.
Abstract

Clinically significant CMV (re)activation during or after radiotherapy/chemotherapy of the brain : Correlation with neurological deterioration and improvement upon antiviral treatment.
Goerig N, Semrau S, Frey B, et al
Strahlenther Onkol. 2016 May 31.
Abstract

FULL-TEXT ARTICLE
Two strategies for prevention of cytomegalovirus infections after liver transplantation.
Simon P, Sasse M, Laudi S,  et al
World J Gastroenterol. 2016 Mar 28;22(12):3412-7.
Paper

Cytomegalovirus load at treatment initiation is predictive of time to resolution of viremia and duration of therapy in hematopoietic cell transplant recipients.
Tan SK, Waggoner JJ, Pinsky BA. et al
J Clin Virol. 2015 Aug;69:179-83.
Abstract 

FULL-TEXT ARTICLE
A Prospective Monitoring Study of Cytomegalovirus Infection in Non-Immunosuppressed Critical Heart Surgery Patients
Lopez Roa P, Perez-Granda MJ, et al
PLoS One. 2015 Jun 12;10(6):e0129447.
Paper

Reprint of: Recent Advances in Cytomegalovirus: An Update on Pharmacologic and Cellular Therapies.
Boeckh M, Murphy WJ, Peggs KS.
Biol Blood Marrow Transplant. 2015 Feb;21(2S):S19-S24.
Abstract 

Diagnosis and treatment of cytomegalovirus 2013.
Einsele H, Mielke S, Grigoleit GU.
Curr Opin Hematol. 2014 Nov;21(6):470-5.
Abstract 

Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation.
Kotton CN, Kumar D, Caliendo AM, . et al
Transplantation. 2013 Aug 27;96(4):333-360
Abstract

FULL-TEXT ARTICLE
Management of cytomegalovirus infection in a patient with malignant glioma treated with temozolomide and steroids.
Okita Y, Narita Y, Miyakita Y,  et al
Intern Med. 2012;51(20):2967-71
Paper